Acetaminophen Completed Phase 2 Trials for Rejection, Transplant Treatment

Indications	Status	Purpose	Phase
DBCOND0030946 (Rejection, Transplant)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00771875	Randomized Trial for Mixed Acute Rejection	Methylprednisolone (DB00959) Rituximab (DB00073) Bortezomib (DB00188) Acetaminophen (DB00316) Diphenhydramine (DB01075) Zinc (DB01593) Antithymocyte immunoglobulin (rabbit) (DB00098)